Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease-Reference-Cited by-同舟云学术

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease

Published:2010-08-22 Issue:9 Volume:16 Page:998-1000
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Lee Byoung Dae,Shin Joo-Ho,VanKampen Jackalina,Petrucelli Leonard,West Andrew B,Ko Han Seok,Lee Yun-Il,Maguire-Zeiss Kathleen A,Bowers William J,Federoff Howard J,Dawson Valina L,Dawson Ted M

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2199.pdf

Reference15 articles.

1. Gasser, T. Expert Rev. Mol. Med. 11, e22 (2009).

2. Greggio, E. et al. Neurobiol. Dis. 23, 329–341 (2006).

3. Smith, W.W. et al. Nat. Neurosci. 9, 1231–1233 (2006).

4. West, A.B. et al. Hum. Mol. Genet. 16, 223–232 (2007).

5. Whaley, N.R., Uitti, R.J., Dickson, D.W., Farrer, M.J. & Wszolek, Z.K. J. Neural Transm. Suppl. 70, 221–229 (2006).

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental Models in Parkinson’s Disease: Advantages and Disadvantages;Ağrı Tıp Fakültesi Dergisi;2024-06-30

2. LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease;Journal of Cellular Physiology;2024-03-13

3. Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation;Coordination Chemistry Reviews;2024-03

4. Role of Animal Models in Parkinson's Disease (PD): What Role They Play in Preclinical Translational Research;CNS & Neurological Disorders - Drug Targets;2024-02

5. Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM;Cell Discovery;2024-01-23